Cooper Researchers Embark on Clinical Study to Test Effectiveness of Innovative Treatment Method
Larry Miller, MD, is principal investigator for this clinical study.
Osteoarthritis — the most common form of arthritis — is a chronic condition that affects over 20 million people in the United States. Osteoarthritis results in sore or stiff joints, limited range of motion, mild swelling around a joint, and pain. It may progress quickly, but for most people, joint damage develops gradually over years. In some people, osteoarthritis is relatively mild and interferes little with day-to-day life; in others, it causes significant pain and disability.
Treatment typically involves symptom relief through exercise, lifestyle changes, and a variety of over-the-counter and prescription medications. Now, researchers at Cooper University Health Care are embarking on an innovative clinical study to test whether extracted fat cells from a patient which are then reinjected into the same patient’s knee can bring relief from osteoporosis pain. Cooper is one of only two clinical institutions in the nation participating in this study.
“We are excited to participate in this clinical trial. Through our research efforts here at Cooper, we are able to test new treatment methods and advance medical knowledge,” said Lawrence S. Miller, MD, Chairman and Chief of the Department of Orthopaedic Surgery, Director of the Cooper Bone and Joint Institute, and principal investigator for the study.
For more information on potential participation on this research study or other clinical trials visit www.ClinicalTrials.gov.
Media Contact:
Wendy A. Marano
Public Relations Manager
marano-wendy@cooperhealth.edu
856.382.6463